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We assume that the high rates of PNTMD in Japan are 
consistent with data suggesting that Asians are particularly 
susceptible to PNTMD (1,7,8). Other factors contributing 
to the increase might be the simplified diagnosis according 
to the 2007 American Thoracic Society/Infectious Diseases 
Society of America statements, increased awareness by 
medical staff, population aging, and increased frequency of 
medical checkups with computed tomography of the chest.
Another finding was the characteristic gradient cluster-
ing of the ratios of M. avium and M. intracellulare (online 
Technical Appendix Figure 2). This finding supports the 
widely accepted belief that environmental factors strongly 
affect the epidemiology of PNTMD; therefore, the role of 
factors such as soil, humidity, temperature, and saturated 
vapor pressure should be seriously considered (9).
We also found dramatic increases in incidence of pul-
monary M. abscessus disease and pulmonary MAC dis-
ease, whereas incidence of pulmonary M. kansasii disease 
was stable. Although we did not distinguish M. massiliense 
from M. abscessus, the incidence rate for pulmonary M. 
abscessus disease increased from 0.1 cases in 2001 to 0.5 
cases per 100,000 person-years in 2014. This epidemiolog-
ic tendency should be monitored (10).
This study has several limitations. First, differing 
characteristics between the responding and nonrespond-
ing hospitals could cause bias. Second, we did not collect 
data outside of hospitals. Third, incomplete reporting could 
undermine the accuracy of our estimates (online Technical 
Appendix Tables 3, 4). Therefore, the epidemiologic data 
should be verified by using other approaches (online Tech-
nical Appendix Table 1). 
The dramatic increase in incidence rates for PNTMD 
warrants its recognition as a major public health concern. 
Because the prevalence rates of this currently incurable 
lifelong chronic disease are estimated to be high, the effect 
on the community could be enormous. Further investiga-
tions are needed.
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To the Editor: Pertussis is a highly communicable, 
acute bacterial respiratory infection caused by Bordetella 
pertussis. In the United States, the incidence of pertussis 
declined dramatically after pertussis-containing vaccine 
was introduced in the 1940s (1,2). However, a resurgence 
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of disease results in widespread outbreaks of pertussis 
nationally (3).
Beginning in August 2011, an outbreak of pertussis 
occurred in New York City (NYC), New York, USA. Re-
ported pertussis incidence by month peaked in December 
2011 (1.03 cases/100,000 persons) and remained above the 
baseline average monthly incidence of 0.11 cases/100,000 
persons until February 2013. We hypothesized that pro-
vider awareness and altered practices after the start of the 
outbreak contributed to the sustained elevation in reported 
pertussis incidence.
To test this hypothesis, we surveyed NYC providers 
to assess their awareness of the outbreak, their consider-
ation of pertussis in symptomatic patients, and the type 
and frequency of diagnostic testing ordered. The survey 
(available on request) was designed in FeedbackServer 
5 (University of Massachusetts, Worcester, MA, USA; 
https://w3.umassmed.edu/fs/FeedbackServer/help/feed-
backserver.htm) and consisted of 20 questions that required 
≈5 minutes to complete by using a Web link. We distributed 
the survey in January 2013 to providers through 3 health 
department email lists: the NYC Health Alert Network, the 
Citywide Immunization Registry, and the Primary Care 
Information Project. The lists included ≈30,000 email ad-
dresses that were not mutually exclusive and that included 
nonmedical providers.
Through March 7, 2013, we received 1,316 responses; 
887 (67%) were excluded from analyses for >1 reason: re-
spondent did not complete all survey questions (74%); re-
spondent did not practice in a hospital or outpatient facility 
(31%); respondent indicated that his or her primary facility 
was located outside NYC (6%); or response was a duplicate 
(<1%). Of the 429 (33%) responses included in our analy-
ses, 69% of respondents served adults and 54% served chil-
dren (23% served both adults and children); 38% practiced 
in a hospital, and 81% practiced in an outpatient setting 
(18% practiced in both hospital and outpatient settings).
Respondents were asked if and how they were aware 
of the pertussis outbreak; 84% reported previous awareness 
of the outbreak. The top reported sources contributing to 
respondents’ outbreak awareness included health advisory 
alerts (local [80%], state [36%], and national [40%]); me-
dia reports (36%); and discussion with colleagues (29%).
In addition, respondents were asked how likely they 
were to consider pertussis infection in patients with pro-
longed cough before 2012 and currently. Reported consid-
eration of pertussis before 2012 varied: 35% of respondents 
were likely or very likely to consider pertussis, 33% were 
somewhat likely to consider pertussis, 30% were unlikely 
to consider pertussis, and 3% did not know (unknown). 
However, 73% of respondents said that they were more 
likely to consider pertussis at the time of the survey than 
before 2012. The top reported sources contributing to in-
creased consideration of pertussis mirrored those contribut-
ing to outbreak awareness.
Respondents were last asked to assess the type and 
frequency of diagnostic testing they used before and since 
2012 (Table). Most (66%) respondents indicated that they 
did not perform diagnostic testing for pertussis before 2012. 
Among the 34% who tested for pertussis before 2012, the 





Table. Provider responses to survey questions related to diagnostic testing for pertussis, New York City, New York, USA* 
Questions and responses No. (%) 
Did respondent perform diagnostic tests for pertussis before 2012?  
 Did not perform diagnostic tests 282 (66) 
 Performed ≥1 diagnostic test 147 (34) 
Which types of diagnostic tests did respondent perform before 2012?†  
 Bacterial culture 68 (46) 
 PCR 66 (45) 
 Serology 35 (24) 
 DFA 41 (28) 
Did respondent change the types of diagnostic tests he/she performed since 2012?‡  
 Yes 52 (12) 
 No 269 (63) 
 Unknown 108 (25) 
Which types of diagnostic tests was respondent more likely to perform since 2012?§  
 Bacterial culture 17 (33) 
 PCR 33 (63) 
 Serology 6 (12) 
 DFA 5 (10) 
 No test 3 (6) 
Did respondent change the frequency of diagnostic tests he/she performed since 2012?  
 More frequent testing 93 (22) 
 Less frequent testing 14 (3) 
 Frequency of testing unchanged 231 (54) 
 No response provided 1 (<1) 
*N = 429 except as indicated. DFA, direct fluorescent antibody test. 
†For 147 respondents who reported performing >1 diagnostic test before 2012. Response choices are not mutually exclusive. 
‡For all respondents, including those who reported not performing diagnostic tests before 2012. 
§For 52 respondents who reported a change in type of diagnostic test performed since 2012. Response choices are not mutually exclusive. 
 
main diagnostic methods used were bacterial culture (46%) 
and PCR (45%). However, 12% of respondents indicated 
that they had changed the type of diagnostic test they used 
beginning in 2012; among these respondents, 33% were 
more likely to use pertussis culture and 63% were more 
likely to use PCR or to use culture and PCR. Of total re-
spondents, 22% indicated that they ordered diagnostic tests 
more frequently since the beginning of 2012.
Our investigation has limitations. We could not deter-
mine a survey response rate because of extensive overlap of 
the email lists used, and we lacked access to the lists; the 
response rate is assumed to be very low. Respondents includ-
ed in the analysis may not have been representative of the 
broader NYC provider community. In addition, respondents 
may not have uniformly interpreted the survey because of the 
subjective nature of some survey questions, and recall bias 
may have affected responses. Also, respondent awareness of 
the outbreak is likely overestimated because the email lists 
used for survey distribution were used during the outbreak to 
distribute health alerts. Despite these limitations, our inves-
tigation shows the value of Web-based surveys distributed 
by email to gather information rapidly from a large provider 
community in a cost-effective and practical manner.
This investigation indicates the importance of provid-
er knowledge and practices for public health surveillance 
data. High awareness of an outbreak, increased clinical 
suspicion of pertussis, and increased frequency of diag-
nostic testing likely contributed to a sustained elevation 
in pertussis incidence. Advisory alerts and media reports 
were successful mechanisms for disseminating information 
to providers during the outbreak and likely altered pro-
vider behaviors that contributed to the increase in reported 
pertussis incidence. Previous reports have documented 
increased submission of disease notifications after media 
coverage of health concerns (4,5). Responses to our survey 
also highlight how pertussis incidence may be routinely un-
derestimated because providers do not suspect the disease 
or test for it consistently.
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To the Editor: Progressive disseminated histoplasmo-
sis (PDH) of infancy occurs most commonly in previously 
healthy infants <1 year of age, typically after exposure to a 
large fungal inoculum (1). Even with treatment, the disease 
is fatal in ≈13% of cases (1). Common symptoms include 
fever, hepatosplenomegaly, lymphadenopathy, and failure 
to thrive. Laboratory abnormalities frequently include cy-
topenia and coagulopathy (1,2). Many clinical manifesta-
tions of PDH overlap with those of the hyperinflammatory 
condition hemophagocytic lymphohistiocytosis (HLH), 
and co-existence of HLH and histoplasmosis has been re-
ported in adults. We report a case of simultaneous PDH and 
HLH in an infant.
A 6-month-old African American girl was brought for 
treatment to St. Jude Children’s Research Hospital in April 
2015 with a 1-month history of daily fever. Her history was 
notable only for a methicillin-resistant Staphylococcus au-
reus skin abscess diagnosed when she was 5 months old; it 
was drained, and she received oral clindamycin.
On initial evaluation, she had fever, lethargy, and hepa-
tosplenomegaly. Laboratory testing showed pancytopenia 
and mild hepatitis, and abdominal ultrasound confirmed 
hepatosplenomegaly. After admission, respiratory distress 
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